Pliant Therapeutics SG&A Expense (Quarterly) Trends

Pliant Therapeutics Inc (PLRX)

13.59 -0.22 (-1.59%) USD | NASDAQ | May 10, 11:15

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	15.25M
December 31, 2023	13.85M
September 30, 2023	15.35M
June 30, 2023	14.57M
March 31, 2023	14.15M
December 31, 2022	14.25M
September 30, 2022	8.823M
June 30, 2022	8.296M
March 31, 2022	8.579M
December 31, 2021	7.846M
September 30, 2021	7.671M

Date	Value
June 30, 2021	5.475M
March 31, 2021	6.566M
December 31, 2020	5.627M
September 30, 2020	4.591M
June 30, 2020	3.04M
March 31, 2020	4.011M
December 31, 2019	3.103M
September 30, 2019	2.583M
June 30, 2019	2.643M
March 31, 2019	2.601M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.583M

Minimum

Sep 2019

15.35M

Maximum

Sep 2023

8.314M

Average

7.758M

Median

SG&A Expense (Quarterly) Benchmarks